Silo Pharma, Inc. (SILO)

Silo Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3.91	3.52	11.37	9.84	1.13
Short-Term Investments	3.17	4.14	0	0.42	0
Cash & Short-Term Investments	7.08	7.67	11.37	10.26	1.13
Cash Growth	-7.63%	-32.58%	10.85%	808.83%	831.59%
Accounts Receivable	0	0	0	0	-
Receivables	0	0	0.07	0	0.02
Prepaid Expenses	0.03	0.01	0.12	0.06	0.13
Other Current Assets	0.01	0.01	0.02	0.08	0.14
Total Current Assets	7.11	7.68	11.57	10.4	1.43
Other Intangible Assets	0.24	-	-	-	-
Long-Term Accounts Receivable	0.01	0.01	0.01	0.01	-
Long-Term Deferred Charges	0.05	0.06	0.06	0.02	-
Total Assets	7.41	7.75	11.64	10.49	1.43
Accounts Payable	1.58	0.7	0.22	0.42	0.13
Accrued Expenses	-	-	0.14	-	-
Current Portion of Long-Term Debt	-	-	-	-	0.01
Current Unearned Revenue	0.07	0.07	0.07	0.07	-
Total Current Liabilities	1.66	0.78	0.44	0.49	0.14
Long-Term Debt	-	-	-	-	0
Long-Term Unearned Revenue	0.72	0.79	0.87	0.94	-
Total Liabilities	2.38	1.57	1.3	1.43	0.15
Common Stock	0	0	0	0	0.01
Additional Paid-In Capital	20.3	17.53	17.51	12.32	7.03
Retained Earnings	-15.26	-10.87	-7.17	-3.26	-5.76
Treasury Stock	-	-0.47	-	-	-
Comprehensive Income & Other	0	-0.01	-	-	-
Total Common Equity	5.03	6.18	10.34	9.06	1.28
Shareholders' Equity	5.03	6.18	10.34	9.06	1.28
Total Liabilities & Equity	7.41	7.75	11.64	10.49	1.43
Total Debt	-	-	-	-	0.02
Net Cash (Debt)	7.08	7.67	11.37	10.26	1.11
Net Cash Growth	-7.63%	-32.58%	10.85%	824.31%	1772.23%
Net Cash Per Share	1.92	2.49	4.98	5.35	0.84
Filing Date Shares Outstanding	4.48	2.84	3.16	1.97	1.7
Total Common Shares Outstanding	4.48	2.91	3.16	1.97	1.7
Working Capital	5.46	6.91	11.14	9.91	1.28
Book Value Per Share	1.12	2.13	3.27	4.59	0.75
Tangible Book Value	4.79	6.18	10.34	9.06	1.28
Tangible Book Value Per Share	1.07	2.13	3.27	4.59	0.75

Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q